Celsius Holdings (CELH) Stock
Key stats
- Market cap
- $8.28B
- Price / Earnings ratio
- 35.7x
- EPS (TTM)
- $0.89
- Volume
- Loading
- 52-week high
- $59.31
- 52-week low
- $23.56
- EPS vs analyst estimate
- +50.0%Q3 FY25 · $0.42 vs $0.28
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with CELH
Recent news
Why Is CELH Stock Rising Today?
Why Is CELH Stock Rising Today?
CELH
Factors to Watch Ahead of Celsius Holdings' Q3 Earnings Release
Factors to Watch Ahead of Celsius Holdings' Q3 Earnings Release
CELH
3 Growth Stocks to Buy in November, Even if the Nasdaq-100 Enters a Correction
3 Growth Stocks to Buy in November, Even if the Nasdaq-100 Enters a Correction
CELH
Celsius accused of ‘health-washing' scheme in new lawsuit
Celsius accused of ‘health-washing' scheme in new lawsuit
CELHNews tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 69.31
- MACD 12/26/9
- 1.10
- EMA 9 of MACD
- 0.60
- MACD histogram
- 0.49
- SMA 50
- $28.82
- Price above SMA 50
- EMA 50
- $29.51
- Price above EMA 50
- SMA 200
- $33.57
- Price below SMA 200
- EMA 200
- $34.37
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.49 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news
Why Is CELH Stock Rising Today?
Why Is CELH Stock Rising Today?
CELHFactors to Watch Ahead of Celsius Holdings' Q3 Earnings Release
Factors to Watch Ahead of Celsius Holdings' Q3 Earnings Release
CELH3 Growth Stocks to Buy in November, Even if the Nasdaq-100 Enters a Correction
3 Growth Stocks to Buy in November, Even if the Nasdaq-100 Enters a Correction
CELHCelsius accused of ‘health-washing' scheme in new lawsuit
Celsius accused of ‘health-washing' scheme in new lawsuit
CELH
Celsius Holdings to Release Third Quarter Results on Thursday, Nov. 5, 2026
Celsius Holdings to Release Third Quarter Results on Thursday, Nov. 5, 2026
CELH
Earnings Preview: Celsius Holdings Inc. (CELH) Q3 Earnings Expected to Decline
Earnings Preview: Celsius Holdings Inc. (CELH) Q3 Earnings Expected to Decline
CELH
Celsius Holdings Inc. (CELH) is Attracting Investor Attention: Here is What You Should Know
Celsius Holdings Inc. (CELH) is Attracting Investor Attention: Here is What You Should Know
CELH
CELH Deadline: Rosen Law Firm Urges Celsius Holdings, Inc. (NASDAQ: CELH) Stockholders to Contact the Firm for Information About Their Rights
CELH Deadline: Rosen Law Firm Urges Celsius Holdings, Inc. (NASDAQ: CELH) Stockholders to Contact the Firm for Information About Their Rights
CELH
Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027?
Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027?
CELH
Celsius Holdings Inc. (CELH) Stock Sinks As Market Gains: Here's Why
Celsius Holdings Inc. (CELH) Stock Sinks As Market Gains: Here's Why
CELHNews tone: automated (AI) classification of the article's content, not a price prediction.
About Celsius Holdings
Celsius Holdings, Inc., is a fast-growing company in the functional energy drink and supplement categories in the United States and internationally, engaged in the development, marketing, sale, and distribution of functional calorie-burning supplements that offer clinically proven and innovative formulas meant to improve the health and wellness of our consumers. CELSIUS® has five beverage lines that include, CELSIUS® Originals, CELSIUS HEAT™, CELSIUS® BCAA +Energy, CELSIUS® On-the-Go, and CELSIUS® Sweetened with Stevia. CELSIUS® has zero sugar, no preservatives, no aspartame, no high fructose corn syrup, and is non-GMO, with no artificial flavors or colors. The CELSIUS® line of products is Certified Kosher and Vegan. CELSIUS® is also soy and gluten-free and contains very little sodium.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. John Fieldly CPA | CEO & Chairman | 1980 |
| Mr. Jarrod Langhans CPA | Chief Financial Officer | 1981 |
| Mr. Richard Stephen Mattessich | Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | 1965 |
| Mr. Tony Guilfoyle | Chief Business Transformation Officer | 1974 |
| Mr. Paul Wiseman | Senior Vice President of Communications & Investor Relations | — |
| Mr. Rishi Daing | Chief Marketing Officer | — |
| Ms. Trinh Lam | Chief Human Resources Officer | 1978 |
| Mr. Toby David | Chief of Staff | — |
| Ms. Kyle Audrey Watson | Chief Brand Officer | 1982 |
| Mr. Brant P. Burchfield | Senior Vice President of Growth & Strategic Planning | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 69.31
- MACD 12/26/9
- 1.10
- EMA 9 of MACD
- 0.60
- MACD histogram
- 0.49
- SMA 50
- $28.82
- Price above SMA 50
- EMA 50
- $29.51
- Price above EMA 50
- SMA 200
- $33.57
- Price below SMA 200
- EMA 200
- $34.37
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $35.00
- Average
- $44.00
- High
- $53.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -12.0 | +18.6 | ||||||||||
| 2022 | -36.4 | +27.4 | -12.1 | -11.4 | +22.9 | -1.0 | +34.8 | +4.7 | -8.6 | -0.2 | +22.9 | -8.2 |
| 2023 | -0.1 | -9.6 | +4.7 | +3.7 | +21.5 | +11.9 | -2.4 | +37.6 | -11.6 | -12.6 | -4.3 | +4.9 |
| 2024 | -15.5 | +59.7 | +4.6 | -13.6 | +10.6 | -23.9 | -19.0 | -15.1 | -14.4 | -3.6 | -9.6 | -8.0 |
| 2025 | -8.2 | +8.1 | +38.9 | -2.2 | +8.6 | +21.8 | -1.4 | +40.6 | -6.4 | +4.7 | -30.9 | +7.3 |
| 2026 | +9.9 | +4.5 | -28.0 | -2.2 | -1.4 | -5.2 | -8.3 | +11.4 | -11.0 | +6.2 | +9.5 |
Corporate actions
Upcoming
No upcoming corporate actions for CELH
